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ABSTRACT
We identi®ed a type II topoisomerase enzyme from
Leishmania infantum, a parasite protozoon causing
disease in humans. This protein, named Li topo II,
which displays a variable C-terminal end, is located
in the kinetoplast. The cloned gene encoding Li-
TOP2 compensates for the slow growth of topo II-
de®cient mutants of Saccharomyces cerevisiae,
resulting in a catalytically active DNA topoisomer-
ase in yeast. Analysis of the speci®c mRNA levels of
the Li-TOP2 gene showed variations throughout the
parasite cell cycle in synchronized cells as well as
between the distinct forms of the parasite. Thus, the
enzyme had higher levels of mRNA expression in
the highly infective intracellular form of the parasite,
the amastigote, than in the extracellular promasti-
gote form, suggesting a relation with the distinct
developmental and infectious phases of the proto-
zoon. In addition, western blot analysis showed
differences in protein expression between the pro-
liferative and non-proliferative forms of L.infantum
promastigotes, which displayed similar levels of
mRNA. This indicated possible post-transcriptional
regulation mechanisms. The data suggest that Li
topo II has a part in DNA decatenation and probably
at the initial stages of proliferation in the intra-
cellular form of L.infantum, a parasite that has to
proliferate into the host macrophage to survive
its hostile environment in its ®rst moments of
intracellular infection.
INTRODUCTION
The parasite protozoa of the genus Leishmania cause disease
in more than 15 million people. Leishmaniasis is endemic in
the tropical and subtropical regions of Africa and America, the
Indian subcontinent and South Asia. It is associated in many
cases with AIDS patients as an opportunistic disease (1,2). The
parasite has two forms, the extracellular promastigotes, which
increase its infectivity before entering the host macrophage,
and the intracellular amastigotes (3). Its developmental
process, related to parasite infectivity, can be mimicked by
promastigotes in liquid medium at the laboratory (4).
The genus Leishmania is among the most primitive
eukaryotes. It belongs to the order of Kinetoplastida, which
bear single mitochondria called kinetoplasts (5). Kinetoplasts
contain an unusual structure formed by a disc-shaped network
of catenated DNA circles (6,7). These circles are divided into
two categories: minicircles (0.5±3 kb), up to several thousand
of which are present, and maxicircles (30±40 kb) of which
there are only a few dozen (8). Minicircles encode the small
guide RNAs that regulate RNA editing, whereas most
maxicircles encode ribosomal RNAs and proteins involved
in energy transduction (9). The replication of kinetoplast DNA
is another unusual feature because it occurs in synchrony with
the replication of nuclear DNA (10), unlike mitochondrial
DNA from higher eukaryotes which replicates through the
whole cell cycle (11). During replication, minicircles inter-
locked with several neighboring molecules are released from
the interior of the network towards the external part of the
structure. The daughter chains are then re-attached to the
network periphery (12). These complex topological problems
are solved by the action of type II topoisomerases (13,14).
These enzymes use ATP to transport one DNA double-helix
backbone through a transient double-strand break that they
create in another (15,16). This mechanism allows type II
topoisomerases to relax, catenate±decatenate and knot±unknot
DNA molecules. These enzymes are essential in DNA
replication and chromosome segregation, and are also
involved in the maintenance of chromosome structure
(17,18). Eukaryotic type II topoisomerases are homodimeric
enzymes comprising three functional domains. The highly
conserved N-terminal domain, which contains the ATP
binding pocket; the core domain, with the active site for
DNA cleavage-rejoining; and the less conserved C-terminal
domain, where the regulatory elements such as phosphoryl-
ation sites and localization signals are located.
Type II DNA topoisomerase activity is speci®cally targeted
by various agents, most of which interfere in the DNA
rejoining reaction catalyzed by the enzyme. These compounds
lead to DNA breaks, which induce subsequent genome
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fragmentation and cell death (15). Therefore, eukaryotic type
II topoisomerases have emerged as an ideal target for
antitumoral or antiparasite drugs (19±21). In the case of
Trypanosomatidae, these enzymes have an additional speci-
®city because they function in the kinetoplast, a structure that
is absent in higher eukaryotes. Nevertheless, the use of type II
DNA topoisomerases as targets for screening of speci®c
inhibitors is not an easy task due to dif®culties in preserving
the stability of the enzyme, mainly its regulatory domain (15).
To our knowledge, no puri®cation of any recombinant type II
topoisomerase from Trypanosomatidae has been reported
(22±24).
We describe here the cloning and functional analysis of a
gene encoding a type II DNA topoisomerase from Leishmania
infantum, the parasite protozoon responsible for visceral
leishmaniasis in the Mediterranean basin. The gene was
identi®ed by sequence comparison and through complement-
ation experiments in Saccharomyces cerevisiae. Immuno-
¯uorescence experiments revealed that the gene product is a
kinetoplast-located enzyme, which achieves higher levels of
expression in the infective intracellular form of the parasite
following post-transcriptional regulation. The relevance of




The parasite strain (MHOM/FR/80/LEM75) was kindly
provided by Dr J. Alvar (Reference Parasitology Service,
Majadahonda, Madrid, Spain). Leishmania infantum pro-
mastigotes were grown at 26°C in RPMI-1640 (Gibco BRL,
Scotland, UK). They were supplemented with 10% heat-
inactivated fetal calf serum (Gibco BRL, Scotland, UK),
penicillin (50 U/ml) and streptomycin (50 mg/ml).
Promastigote cultures were initiated at 1 3 106 cells/ml and
harvested at logarithmic and stationary phases of growth, as
de®ned by morphology and cell concentration (25).
The amastigote phase of the parasite was obtained by
infecting an X-ray-irradiated (100 rads in a single exposition)
monolayer of J774 cells grown on 75-cm2 tissue culture ¯asks
(Costar, Cambridge, MA, USA) with stationary phase
promastigotes (107 cells/ml) in culture medium (20:1, para-
site/cell ratio). The infected cells were incubated at 37°C in a
5% CO2 atmosphere for 6 days to allow development of the
L.infantum amastigotes into macrophages (26). This process
was followed up by phase-contrast microscopy (ELWD 0.3;
Nikon, Japan).
Synchronous cultures
Leishmania infantum promastigotes (7 3 106 cell/ml) were
incubated for 6 h in medium containing 200 mg/ml hydroxy-
urea (27). Synchronous cells were harvested by centrifugation
at 2000 g for 10 min at room temperature and suspended in the
same volume of fresh medium lacking hydroxyurea.
Leishmania infantum promastigotes remained synchronous
for ~6 h. Samples of 10 mg of RNA were taken every 30 min
for further northern blot analysis (see below).
Oligonucleotides and DNA probes
Oligonucleotides LiF1 (AAGCTGACGAACATTCTTTC-
CACTAA) and LiR2 (GAGGCCTCGCCGTGGTGAAAC),
designed according to the conserved regions of the sequences
of the DNA TOP2 family, were used for reverse transcription±
polymerase chain reaction (RT±PCR) ampli®cation under the
following conditions: with 1 min at 95°C, 1 min at 55°C and
2 min at 72°C, a fragment of 1985 bp was obtained. The 5¢-
terminal end was ampli®ed with the spliced leader oligo-
nucleotide SL (5¢-ATCAGTTTCTGTACTTTATTG) and the
LiR3 oligonucleotide (5¢-AGACGACGGAGAACTTAGTG-
GAAAG). The 3¢-terminal end was ampli®ed (3¢-RACE) with
a speci®c oligonucleotide from the known sequence LiF2 (5¢-
CGGTGCGGGCCATGATCAAC) and the oligo(dT) primer
[5¢-GCGCCAGGAATTCGC (dT17)]. The DNA probes for
the encoding sequence of Li-TOP2 were labeled with
[a-32P]dCTP, using the Random Primed DNA Labeling Kit
(Boehringer Mannheim, Germany).
Expression of L.infantum TOP2 in Escherichia coli
The open-reading frame containing the DNA TOP2 from
L.infantum was cloned into a pQE/.REP4 bacterial expression
vector, which allows the expression of recombinant proteins as
fusions with a multifunctional leader peptide containing a
hexahystidyl sequence for puri®cation on Ni++-af®nity resins
(28). The open-reading frame of Li-TOP2 was PCR-ampli®ed
using oligonucleotides containing SphI and HindIII restriction
sites, 5¢TOP SphI (5¢-GCGCGCATGCATGACAGACGCT-
TCCA-3¢) and 3¢TOP HindIII (5¢-GCGCAAGCTTTTACAT-
CAAAACATGTGGC-3¢). The resulting 3.7 kb PCR product
was cloned at the SphI/HindIII sites of vector pQE30 (Qiagen,
Germany). The construction of the recombinant expression
plasmid, named pQ30-Li TOP2, was con®rmed by DNA
sequencing. Expression of the His6-tagged protein was carried
out in the M15 E.coli strain, which contains the pREP4
repressor plasmid and the T5 promoter under the control of
isopropyl-b-D-thiogalactopyranoside (IPTG)-regulated lac I
gene (29). Cells were transformed with the pQE30 plasmid
and grown in 37°C Luria±Bertani medium until the optical
density (OD) reached 0.6 (~6 h). Then, IPTG was added to a
®nal concentration of 1 mM and the incubation was continued
for 4 h at 26°C to reduce the inclusion bodies. Cells were
collected by centrifugation at 4000 g for 20 min and lysed in
buffer A (6 M Gu-HCl, 0.1 M sodium phosphate, 10 mM Tris±
HCl, pH 8.0). The suspension was cleared by centrifugation at
10 000 g for 20 min and the supernatant containing the
recombinant protein was used for the puri®cation process. A
1.1 kb fragment from the N-terminal domain was ampli®ed
using a sense primer with a SphI site 5¢-GCGCGCATGCAT-
GACAGACGCTTCCA-3¢ and an antisense primer with a
HindIII site 5¢-GCGCAAGCTTTTAGAGCTGGTCGTC-
CAT-3¢. The ampli®cation product was cloned at the SphI/
HindIII sites of vector pQ30 (Qiagen) to obtain a pQ30-
LiTOP2-1.1 kb construct encoding for a 40 kDa topo II
fragment used to obtain speci®c antiserum. Induction, over-
production and solubility of the recombinant proteins were
analyzed by 10% polyacrylamide gel electrophoresis (PAGE)
in the presence of SDS and viewed by Coomassie blue
staining. Western blot analysis was carried out as described
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(30,31). In all cases, unless otherwise indicated, 10 mg of
protein were loaded per well.
Puri®cation of Li topo II and Li topo II-1.1
Ni++-NTA agarose beads (Qiagen) previously equilibrated
with buffer A (see above), were incubated for 30 min at room
temperature with the soluble fraction containing the recombin-
ant protein, as described above. The resin was loaded into a
column and washed with 10 ml of buffers B (8 M urea, 0.1 M
sodium phosphate, 10 mM Tris±HCl, pH 8.0) and C (8 M urea,
0.1 M sodium phosphate, 10 mM Tris±HCl, pH 6.3). The
recombinant protein was eluted in 1 ml fractions with 5 ml of
buffers D (8 M urea, 0.1 sodium phosphate, 10 mM Tris±HCl,
pH 5.9) and E (8 M urea, 0.1 M sodium phosphate, 10 mM
Tris±HCl, pH 4.5). The fractions were analyzed by SDS±
PAGE. The amount of protein was quanti®ed by the method of
Bradford (32).
Southern and northern blot analysis
Genomic DNA was isolated from L.infantum promastigotes
following standard procedures, digested with different restric-
tion endonucleases, subjected to electrophoresis in 0.8%
agarose gels and transferred to nylon membranes (33). Blots
were hybridized at 65°C for 16 h in hybridization buffer
(Amersham Pharmacia Biotech, UK), containing 100 mg/ml
denatured salmon sperm DNA. Filters were washed once at
room temperature for 10 min in 23 SSC followed by two
washes for 15 min at 65°C, 2% SDS and two additional
washes for 10 min at 65°C in 13 SSC containing 1% SDS.
Leishmania infantum total RNA was obtained from the
distinct parasite forms and prepared as described (31). Total
RNA was isolated from the synchronous culture every 30 min
using TRIzol (Gibco BRL, NY). For analysis, 10 mg of total
RNA were fractionated in formaldehyde agarose gels and
transferred onto nylon membranes following standard pro-
cedures (33). The blots were hybridized with the PCR probe
described for the Li-TOP2 coding region (see above) and
washed as described above. Blots were analyzed by auto-
radiography and bands were scanned and quanti®ed by using a
Molecular Dynamics Computer Densitometer and Image
Quant Software 3.3 program. To avoid sampling errors,
densitometry scanning of ethidium bromide-stained gels was
carried out.
RNA extraction and semi-quantitative RT±PCR
Total RNA was isolated from each life cycle form using the
TRIzol Reagent (Gibco BRL, NY) according to the manufac-
turer's protocol. RNA from the intracellular amastigotes was
obtained directly from the infected macrophages as previously
described (34). Before reverse transcription, genomic DNA
was removed by incubating with 10 U of DNase I-RNase free
(Boehringer Mannheim). Two micrograms of RNA were
reverse-transcribed using the First Strand cDNA Synthesis Kit
for RT±PCR (Boehringer Mannheim) with random hexamers
in a 20 ml reaction. Semi-quantitative RT±PCR conditions
were established in our laboratory to allow comparisons
between the expression of Li-TOP2 mRNAs and the rRNA
S24a transcript. The number of cycles, 26, used in this
experiment was kept to a minimum. The relative expression of
Li-TOP2 mRNA was determined by using 1 ml of cDNA of the
different parasite life cycle forms, 10 ml of a 103 Amplitaq
Gold buffer, 2 mM MgCl2, 200 mM of each dNTP, 5% DMSO,
250 mM of forward and reverse primer for the Li-TOP2 gene
(TOP2 F33, 5¢-TTATTACAGAGGGTGACTCTGCGAA-3¢
and TOP2 R35, 5¢-AGACCTTTGTAGTACTTGGCCGTG-
3¢) and for the ribosomal control (rRNA F, 5¢-CCCGGG-
AAACCCAGGTGGAGGCC-3¢ and rRNA R, 5¢-CCGGTG-
GATTCGGTTGGTGAGTTGTT-3¢), 2.5 U of AmpliTaq
Gold DNA polymerase and water to 100 ml. PCR conditions
were as follows: denaturation for 30 s at 94°C; annealing for
30 s at 60°C; extension for 30 s at 72°C, for 35 cycles for Li
TOP 2 and 25 cycles for rRNA S24a ampli®cation. As a
negative control, RT±PCRs were performed in the absence of
reverse transcriptase. The size of the Li-TOP2 and rRNA
S24a amplicons were 460 and 470 bp, respectively. These
were the optimal conditions for the semi-quantitative analysis
of Li-TOP2 mRNAs, which was limited to the products
generated during the exponential phase of ampli®cation. The
PCR products were analyzed on 1.5% TAE agarose gels.
Southern transfer and hybridization were performed under the
same stringent conditions indicated previously. Blots were
hybridized with the probes for the Li-TOP2 gene and the S24a
ribosomal control, and analyzed by autoradiography. The
bands were scanned and quanti®ed using a Molecular
Dynamics Computer Densitometer and the Quant Software
3.3 program. The experiments were carried out independently
three times and all points were determined in duplicate.
Enzyme activity determination throughout the parasite
life cycle
Cell extracts were prepared from 1 3 107 parasites in each life
cycle form. Parasite pellets were washed once with PBS and
lysed by the addition of 12 ml of DNA topo II assay buffer
(50 mM Tris±HCl pH 8.0, 120 mM KCl, 10 mM MgCl2,
0.5 mM each of ATP and DTT), to which 100 mg/ml PMSF
and 2 mg/ml leupeptin had been previously added. The lysate
was centrifuged at 12 000 g at 4°C to remove the insoluble cell
debris.
Decatenation assays containing 200 ng of kinetoplast DNA
(35) were carried out in a ®nal volume of 20 ml of lysis buffer.
The reactions were performed at 30°C for 30 min and were
stopped by the addition of 63 loading buffer (100 mM EDTA
pH 8.0, 60% sucrose, 0.1% bromphenol blue, 0.1% xylene
cyanol). The products of the reaction were fractionated by size
on a 1% agarose gel containing 0.5 mg/ml ethidium bromide.
Phylogenic comparisons
Three different segments of the Li topo II were used to
generate the data matrix to infer the phyletic relationships of
the members of the type II topoisomerase family: (i) the
complete sequence of the enzyme; (ii) the N-terminal segment
including the ®rst 800 amino acids spanning the most
conserved portion of the topo II proteins; and (iii) the
C-terminal segment spanning from residue 800 to the end of
the polypeptide. The proteins aligned are in the SWISS-
PROT, GenBank, EMBL and dbEST databases, and the
corresponding identi®ers are: Homo sapiens a isoform
(NP_001058); Homo sapiens b isoform (NP_001059); Mus
musculus (NP_035753); Drosophila melanogaster (P15348);
S.cerevisiae (P06786); L.infantum (AF86355); Crithidia
fasciculata (P27570); Chlorella (NP048939); Arabidopsis
thaliana (NP189031). The multiple alignments were carried
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out using the CLUSTALW program. The phylogenetic trees
derived from the multiple alignments were viewed with the
Tree View program developed by Rod Page.
Speci®c antibodies and immuno¯uorescence localization
New Zealand rabbit speci®c polyclonal antiserum was
obtained with 800 mg of puri®ed Li topo II 40 kDa fragment,
administered in four weekly subcutaneous shots: the ®rst one
in Complete Freund's Adjuvant and the following in
Incomplete Freund's Adjuvant. After one additional week,
the rabbit was bled, the serum obtained, decomplementarized
at 55°C for 1 h and subsequently stored at ±20°C.
Immuno¯uorescence was carried out as described (36) with
slight modi®cations. In short, 106/ml promastigotes were
washed twice with phosphate-buffered saline (PBS) contain-
ing 1% fetal calf serum and 0.1% sodium azide and
resuspended in the same PBS solution with identical ®nal
cell concentration. Twenty-®ve microliters were spotted onto
12 mm round cover slips. After 1 h at 37°C, the cells were
treated with methanol/acetone (1:1) for 15 min at ±20°C. The
®xed cells were incubated for 15 min at room temperature in
DAPI-methanol (0.1 mg/ml). After an additional washing with
methanol, the cells were treated with PBS containing 0.5%
Triton X-100 for 5 min and incubated in a humidity chamber
for 1 h at room temperature with rabbit polyclonal anti-Li-
topoII-40 kDa fragment antibodies, diluted 1:200. After
washing in PBS, cells were incubated with anti-rabbit IgG-
FITC (Dako, Denmark), diluted 1:2000, for 1 h. After washing
with PBS, the slides were mounted with Mowiol (Calbiochem,
CA) and observed through a Zeiss Axioplan microscope. The
images were captured by a Hamamatsu CCD camera and
processed in Adobe Photoshop on a Mackintosh computer.
Complementation of Li-TOP2 gene
Yeast strains. The topoisomerase-de®cient strain JCW28
(Dtop1 top2-4) derives from FY251 (TOP1 TOP2 MATa
his3-D200 leu2-Dl trp1-D63 ura3-52). The thermo-sensitive
mutation top2-4 was obtained by one-step gene replacement
(37), and the null mutation Dtop1 was obtained by the hit-and-
run method of gene replacement (38). Conditionally de®cient
yeast cells were transformed by the lithium acetate method
and cultures grown in synthetic selective or rich media (39).
Plasmids. Construction of pEMBL-LiTOP2: the L.infantum
topoisomerase II gene was PCR-ampli®ed with the
primers LiT2Bam and LiT2Hind. Primer LiT2Bam, 5¢-GCG-
CGGATCCCGTAACCATGTCAATCGCTTCCAAGTAT-
AAGCTC-3¢, created a BamHI site (in bold) upstream of
the coding sequences (underlined). Primer LiT2Hind, 5¢-
GCGCAAGCTTTTAGTGATGGTGATGCACAAAACAT-
GTGG-3¢ created a HindIII site (in bold) at the end of the
coding sequences (underlined). The PCR products were
inserted in regular cloning vectors and the BamHI-HindIII
DNA fragment containing the topoisomerase II coding
sequence was then inserted downstream of the yeast GAL1
promoter in pEMBLyex4 plasmid.
DNA relaxation activity of L.infantum topoisomerase II
in Dtop1 top2-4 yeast cells
YeptopA-PGPD (LEU) is a derivative of Yep13, which carries
the E.coli topA gene under the yeast GPD promoter. This
vector provides constitutive expression of E.coli topo-
isomerase I in yeast (40). Yeast DNA isolation and blot
hybridization DNA from yeast cells was prepared from yeast
spheroplasts (41). Blot hybridization (42) used 32P-labeled
DNA probes obtained by random priming of gel-puri®ed DNA
sequences.
Cultures containing 2% glucose or 2% galactose of JCW28
cells harboring YEptopA-PGPD(LEU) plus pEMBLyex4 or
pEMBL-LiTOP2 were set as described (see above). Cultures
were shifted to 35°C for 2 h 30 min before cell harvesting.
Extracted DNA samples were examined by two-dimensional
electrophoresis in a 0.6% agarose gel, run in TBE buffer plus
0.6 and 3 mg/ml chloroquine in the ®rst (top to bottom, 12 h at
60 V) and second (left to right, 6 h at 60 V) dimensions,
respectively. The gel was blot-hybridized with a 32P-labeled
probe to reveal the 2m yeast plasmid (6.3 kb).
RESULTS
Identi®cation and cloning of L.infantum TOP2 gene
The complete cDNA encoding sequence of the Li topo II
polypeptide was obtained by RT±PCR. First, speci®c
oligonucleotides were designed according to conserved
sequences of type II topoisomerases from different species
to obtain a central region of the gene of 1985 bp. In a
subsequent step, the 5¢ and 3¢ ends were obtained by the same
procedure using speci®c oligonucleotides from the known
sequence and oligonucleotides containing speci®c sequences
for the `spliced leader' and the mRNA poly(A) tail (5¢-RACE
and 3¢-RACE, respectively). Additionally, a 5¢ ¯anking
sequence of 520 bp was obtained. The open-reading frame
3711 bp long (GenBank accession no. AF86355), with a high
percentage (60.5%) of its codons ending in G or C as described
for the genes of the genus Leishmania (43), encodes a 1237
amino acid protein for an estimated molecular mass of
136 kDa, predicted to be a type II topoisomerase.
Leishmania infantum topo II belongs to the type II
topoisomerase family
The hypothesis that Li topo II was a member of the type II
topoisomerase family was con®rmed by multiple amino acid
sequence alignment of Li topo II with H.sapiens,
D.melanogaster, C.fasciculata and S.cerevisiae topo II
proteins, as well as with other Trypanosomatidae. The 1237
amino acid residues of Li topo II were 91% identical with
other closely related species, Leishmania chagasi
(AAC05295) and Leishmania donovani (AAD34021). In the
case of other Trypanosomatidae, there was 78% identity with
the topo II of C.fasciculata, and 64 and 61% with
Trypanosoma cruzi and Trypanosoma brucei. For topo II
enzymes from humans, Drosophila and yeast, identities were
28, 34 and 32%, respectively. Li topo II contained the residues
that are invariant in all type II topoisomerases, including the
tyrosine involved in enzyme transesteri®cation with the DNA
phosphate group (residue 775). Interestingly, Li topo II
contained two of the three leading nuclear sequences
described (44) at residues 998 (KRRR) and 1165 (PPSKRR)
(see below). The alignment also showed that the Li topo II
enzyme is shorter than the polypeptides from other eukary-
otes, as it has deletions at the N-terminal and C-terminal ends.
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The similarities between the Li topo II and the rest of the
enzymes considered were higher at the N-terminal end and
decreased after the active site tyrosine towards the C-terminal
end, as shown in Figure 1A, which displays the alignment of
the C-terminal ends of the enzymes.
Figure 1B shows the phylogenetic trees deduced from the
proteins belonging to the type II topoisomerase family from
lower and higher eukaryotes and one virus protein. The trees
were obtained with the full proteins, with the N-terminal end
sequences (Fig. 1B.1) or the more variable C-terminal ends
(from residue 948 to the end, Fig. 1B.2). The tree for the
complete polypeptides ®ts with the one for the N-terminal
polypeptides. In this tree, Li topo II has an intermediate
position close to yeast and between the higher eukaryotes
(from human to Drosophila) and the Chlorella and
Arabidopsis enzymes which are furthest away from mam-
mals'. In relation to the humans, L.infantum polypeptide was
closer to the beta isoform enzyme than to the alpha one. This
phylogenetic distance is clearly modi®ed when the tree
includes only the protein domains containing the more
variable C-terminal ends. In this case, the topo II proteins
appear to be grouped not according to their eukaryotic or
prokaryotic af®liation, as expected, but to the type of organism
considered, uni- or pluricellular. The polypeptide for
Leishmania appears at one of the extremes of the tree, close
to the Chlorella virus and closer to human than to Drosophila
among the higher eukaryotes. In all cases, A.thaliana is at one
extreme of the tree. The C-terminal end sequence in
Trypanosomatidae and in Leishmania seems to be especially
divergent and confers a higher degree of variability on the type
II topoisomerase than on the other eukaryotes.
Li topo II over-expression in E.coli
Li topo II was expressed in the E.coli strain M15 (Fig. 2A) (see
above). The IPTG induced new polypeptides to migrate to the
expected position. Based on the His6 tag present at its
N-terminal end, the recombinant protein can be puri®ed in a
Ni2+-NTA af®nity chromatography column. However, the
protein had a transient life as a complete polypeptide and is
quickly degraded into minor polypeptides, mainly of 80 and
40 kDa, even in the presence of protease inhibitors (data not
shown). Although the puri®ed fraction showed topoisomerase
activity (see Materials and Methods), this activity cannot be
used as a reference for puri®cation in this case, due to the
existence in the recombinant cells of an accompanying
activity coming from E.coli, topoisomerase IV, a potent
decatenase (45). This topo IV activity may be retained by
unspeci®c binding during the puri®cation process, would not
be detectable as a band by PAGE (see below) and might
be responsible for the topoisomerase activity of the
puri®ed fraction. The expression of Li topo II was
attempted in S.cerevisiae, but the recombinant protein
expressed was not enough to allow its puri®cation (data not
shown).
A stable 40 kDa fragment of the Li topo II protein was
speci®cally cloned, expressed and puri®ed using an identical
procedure (Fig. 2B). This region was chosen because it
corresponds to the most conserved region among different
type II topoisomerases (see above). This fragment was used to
obtain the speci®c antibody against Li topo II that was fully
reactive against the whole protein in western blot and
immuno¯uorescence experiments (see below).
Li topo II is encoded by a single gene and is
differentially expressed throughout the cell cycle
The molecular analysis of the TOP2 gene by Southern blotting
showed a clear pattern. The enzymes HindIII and XhoI, which
showed no target in the encoding sequence, gave a single
hybridization band, whereas BclI, ScaI, SmaI and ClaI, which
showed a single target within the sequence, gave two
hybridization bands (Fig. 3). This analysis and the presence
of a single RNA band in the corresponding northern blot
analysis (Fig. 4A) indicated the existence of a single encoding
gene.
In the 5¢UTR sequence there is a hexameric ATAGAA
sequence that has been considered responsible for mRNA
cyclic expression during the cell cycle in C.fasciculata (46).
Thus, the expression of Li-TOP2 was analyzed along the
distinct cell cycle phases of the parasite. The use of
hydroxyurea, which is lethal for the cells in S phase, allows
synchronization of the protozoa culture. Once removed from
the culture medium, the synthesis of the nuclear and
kinetoplast DNA starts, and the synchronous cell cycle lasts
at least for two generations. The northern blot analysis of the
samples obtained at 30 min periods showed that the levels of
Li-TOP2 mRNA varied throughout the cell cycle. A single
band for a molecular mass of 4.8 kb with a maximum
expression at 60 and 120 min was observed (Fig. 4A).
Semi-quantitative RT±PCR provided a more precise evalu-
ation of the differences in the abundance of Li-TOP2 gene
mRNA transcripts during the different life cycle stages of
L.infantum (34). Figure 4B shows the curves for the relative
levels of expression of Li TOP2 mRNA in logarithmic and
stationary promastigote forms, as well as in amastigote forms.
As a control, we used the ribosomal transcript S24a, which is
expressed at a constant level in all three stages of the life cycle
of L.infantum (47). Figure 4C shows the relative ratio (34)
resulting from three independent experiments of the Li-TOP2
transcript expression in the distinct forms of the parasite,
relative to the constant expression of the ribosomal transcript
S24a. The data indicate that there are differences between the
distinct forms of L.infantum, with a more than 20% increase in
mRNA Li-TOP2 expression in the amastigote intracellular
form. Interestingly, the extracellular promastigote form
showed no differences in mRNA expression between the
proliferative logarithmic phase and the non-proliferative
stationary phase.
Li topo II protein expression was measured by western
blotting of L.infantum cell extracts obtained from samples
taken at the different growth phases. The expression of the
protein was clear in promastigotes at the proliferative
logarithmic phase, whereas the protein was absent at the
infective stationary phase, although here there was a high level
of mRNA expression (see Fig. 4C and D). The DNA type II
topoisomerase activity was examined by using a decatenation
activity assay (see Materials and Methods). The presence of
topo II activity in the cell extracts corresponding to logarith-
mic and stationary promastigotes was measured by decaten-
ation assays in agarose gels (35). Figure 4E shows the
presence of bands corresponding to free minicircles in
addition to the kDNA band in the samples treated with
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logarithmic cell extracts, whereas the samples treated with
parasite extracts from the stationary phase did not show these
minicircle bands, which indicated the absence of topo II
activity. Thus, the enzyme is present and functionally active in
the logarithmic growth phase of L.infantum and is absent in
the non-proliferative stationary phase, regardless of the
existence in this phase of mRNA transcripts at similar levels
to those in the active logarithmic phase.
Leishmania infantum TOP2 compensates for the slow
growth of Dtop1 top2-4 yeast mutants
To verify the functionality of L.infantum TOP2, its compen-
satory effects in topoisomerase-de®cient yeast cells were
examined. The Li-TOP2 gene was inserted downstream of the
galactose-inducible GAL1 promoter in the yeast multicopy
vector pEMBLyex4. Transformants of the topoisomerase-
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Figure 1. (A) Multiple amino acid alignment of C-terminal ends of topo II enzymes from different species. Black columns represent identical residues and
gray columns represent homologous residues. (B) Phylogenetic trees showing the evolutionary distances between members of the topo II family. The species
employed were: H.sapiens a isoform (NP001058); H.sapiens b isoform (NP_001059); M.musculus (NP035753); D.melanogaster (P15348); S.cerevisiae
(P06786); L.infantum (AF86355); C.fasciculata (P27570); Chlorella (NP048939); and A.thaliana (NP189031). The multiple alignments were carried out using
the CLUSTALW program. The phyletic trees derived from the multiple alignments were viewed by the Tree View program developed by Rod Page. For
further experimental details, see Materials and Methods.
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de®cient strain JCW28 (Dtop1 top2-4), harboring either
pEMBLyex4 or pEMBL-LiTOP2, were grown at 26°C in
liquid media containing different amounts of glucose and
galactose, and its duplication times were monitored. As
summarized in Figure 5, cells carrying pEMBLyex4 duplic-
ated approximately every 8 h in media containing 2% glucose,
and approximately every 9 h in media containing 2%
galactose. These values are four times slower than those of
the parental strain FY251 (TOP1+, TOP2+). However, when
JCW28 cells carried pEMBL-LiTOP2, they grew faster as the
galactose/glucose ratio steadily grew. Its duplication time was
reduced to ~5 h in media containing 2% galactose. This
growth rate compensation is comparable with that achieved
when S.cerevisiae topoisomerase I or II is expressed from
plasmid-borne genes in the JCW28 strain (48,49). Yet, when a
similar experiment was done at 35°C, cells were unable to
grow due to the temperature-dependent lethality of the top2-4
mutation. This indicated that the expressed Li topo II was not
enough to substitute all essential functions of the yeast
topoisomerase II.
The product of the Li-TOP2 gene is a catalytically
active topoisomerase II
Further evidence that the product of the Li-TOP2 gene is
catalytically active was obtained by examination of its effects
on DNA topology in yeast cells. In S.cerevisiae, DNA
supercoils are relaxed by yeast topoisomerases I and II.
Unbalanced relaxation of positive and negative supercoils
occurs when yeast topoisomerases are inactivated, and the
E.coli topoisomerase I is expressed from a plasmid-borne
gene. Because this bacterial enzyme only removes negative
supercoils, yeast DNA will rapidly accumulate positive
supercoils unless other topoisomerase activity removes them
(49,50). The experiment described below shows that the
positive supercoiling generated by the unbalanced activity of
E.coli topoisomerase I does not accumulate when L.infantum
topoisomerase II is expressed.
JCW28 (Dtop1 top2-4) cells carrying YEptopA-PGPD-
(LEU), a plasmid that provides constitutive expression of
E.coli topoisomerase I, were transformed with either
pEMBLyex4 or pEMBL-LiTOP2. Single colonies of these
transformants were grown at 26°C in selective media (±ura,
±leu) containing either 2% glucose or 2% galactose. When
cells reached exponential growth (OD ~0.7), cultures were
shifted to 35°C to inactivate yeast topoisomerase II. After 2 h
30 min, cells were harvested and DNA was extracted to
examine the topology of the yeast 2m circle by two-
dimensional gel electrophoresis (Fig. 6). When the cells
harbored pEMBLyex4 and grew in either glucose (lane 1) or
galactose (lane 2), the 2m circles migrated as a single spot
(S+), which corresponds to positively supercoiled DNA in
these gel conditions. However, when the cells harbored
pEMBL-LiTopoII (lanes 3 and 4), the topology of the 2m was
different. In the cells that grew in glucose (lane 3), positive
supercoils accumulated but to a lesser extent than in lanes 1
and 2. In the cells that grew in galactose (lane 4), positive
supercoils did not accumulate and most of the 2m circles
migrated as a characteristic arch of topoisomers (R).
Therefore, an activity able to remove DNA supercoils was
present in the cells harboring pEMBL-LiTopoII that grew in
galactose.
Localization of Li topo II detected by
immuno¯uorescence
Immuno¯uorescence detection of Li topo II in Leishmania
parasites used speci®c polyclonal antibodies raised against a
1143 bp (40 kDa) recombinant fragment (see above).
Simultaneous DAPI staining enabled the DNA of the nucleus
and kinetoplast to be traced. The speci®c immuno¯uorescence
Figure 2. Li topo II over-expression and Li topo II-1.1 puri®cation.
(A) Coomassie blue staining of Li topo II over-expression. Lane 1, E.coli
M15 strain; lane 2, E.coli M 15 strain harbored with plasmid pQE30; lane
3, E.coli M15 strain harbored with the plasmid pQE30-Li-topo II without
IPTG; lane 4, E.coli M15 strain harbored with the plasmid pQE30-Li-topo
II after 4 h of addition of IPTG. (B) Expression of Li topo II-1.1 polypep-
tide fragment (40 kDa) by an E.coli M15 strain harbored with the pQE30-Li
topo II-1.1 plasmid before (not induced) and after (induced) the addition
of IPTG and protein puri®cation on Ni++-af®nity resin. For further
experimental details, see Materials and Methods.
Figure 3. Molecular gene analysis of Li-TOP2 gene. Southern blot analysis
and physical map of Li-TOP2 gene deduced from its nucleotide sequence
with the location of the restriction enzymes used. Leishmania infantum
genomic DNA was subjected to total digestion with the indicated restriction
enzymes. For further experimental details, see Materials and Methods.
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of the protein appeared as two spots located at the kinetoplast
disc (Fig. 7B), coinciding with the mitochondrial topo II at the
related species C.fasciculata but different from T.cruzi in
which it is located in the nucleus (51,52). This immuno-
¯uorescence pattern corresponds to the promastigote form in
the logarithmic phase. At the stationary phase, there was no
¯uorescent signal (data not shown), as expected from the
previous data.
DISCUSSION
DNA type II topoisomerases evolved to solve the topological
problems of DNA, mainly due to its double-helix structure
(18). Thus, these enzymes seem to be indispensable for
chromosome condensation and segregation (17,53,54), so that
the absence of type II topoisomerases coincides with the loss
or breakage of chromosomes (54). The structural problems
created during DNA replication and transcription (55,56) also
require the action of these enzymes to eliminate the resulting
torsional stress (18,57,58). The absence of the type II beta
enzyme affects neuronal differentiation in mammals (59).
Type II alpha is absolutely required for chromosome segre-
gation (60) in higher eukaryotes. In addition, its absence
dramatically increases gene recombination in yeasts (48).
A few topo II enzymes with different cell locations have
been described in Trypanosmatidae. Thus, whereas in
C.fasciculata topo II is located at the kDNA, in T.cruzi the
enzyme is located at the nucleus (44,61). In L.donovani it is
Figure 4. Differential expression of Li topo II throughout the cell and parasite life cycle. (A) Northern blot analysis using 5 mg of total RNA extracted from
L.infantum promastigotes taken from hydroxyurea-synchronous cell culture at different times (indicated in minutes). (B) Levels of expression by RT±PCR of
S24a L.infantum ribosomal protein mRNA (control) and Li topo II mRNA from logarithmic (Log) and stationary (Sta) promastigotes as well as in intra-
cellular amastigotes (Amas). (C) Relative levels of expression of Li topo II mRNA transcripts in the different L.infantum phases: logarithmic (Log), stationary
(Sta) promastigotes and amastigotes (Amas). (D) Western blot analysis of the levels of Li topo II at the logarithmic and stationary phases of the parasite.
(E) Decatenation activity assay of the Li topo II enzyme in cell extracts from the logarithmic (Log) and stationary (Sta) phases of L.infantum promastigotes.
The positions of open circular (OC) and covalently closed circular (CCC) DNA products are indicated. For further experimental details, see Materials and
Methods.
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found at both the nucleus and the kinetoplast (24). Functional
inhibitory studies with RNA interference in T.brucei showed a
striking loss of kinetoplast DNA after interference of TOP2
transcripts. Free minicircle intermediates accumulated: these
coincided with growth inhibition and cell death in many cases
(62,63). Thus, whether it is one or two enzymes that act on the
nucleus and kinetoplast is not yet resolved.
The Li topo II enzyme described here is located at two
antipodal sites ¯anking the kDNA and not in the nucleus as in
T.brucei (62) and the related L.donovani (24). This happens
regardless of the existence in the enzyme polypeptide of two
out of the three nuclear leading sequences described and a high
percentage of identity in the amino acid residues. These
differences in location may be explained by the distinct
epitopes recognized by the different antisera; although the
possibility that Trypanosomatidae may have a different topo II
in the kinetoplast than that in the nucleus cannot be excluded.
Therefore, it is tempting to speculate about the existence of
two closely related enzymes that play a similar role, but are
targeted to different subcellular compartments.
This is, to our knowledge, the ®rst TOP2 gene that has been
unequivocally identi®ed in Trypanosomatidae by functional
studies such as partial gene complementation and measure-
ment of the enzyme activity in yeast. Thus, Li-TOP2 is shown
to compensate for the slow growth of functionally active
Dtop1-top2-4 yeast cells, as measured by yeast DNA relax-
ation. The enzyme had a high degree of variability in the
C-terminal end domain of the polypeptide, as shown by the
phyletic comparisons. The fact that a putative role in
chromosome segregation was assigned to this domain through
speci®c interactions with other proteins required for this
key cell function (58) makes it especially interesting in a
parasite like Leishmania, which does not condense de®nite
chromosomes during mitosis (3).
Li-TOP2 gene is differentially expressed throughout the
cell cycle and the different phases of the parasite. Thus, Li
topo II is cell cycle regulated, present in the replicative
logarithmic phase of the parasite and absent in the non-
replicating, infectious metacyclic promastigotes. However,
the detected level of mRNA transcripts is similar in both cell
stages. Therefore, it seems to be post-transcriptionally regu-
lated. This could be done either by keeping this mRNA pool in
a special subcellular organelle unavailable to the translation
system or by the action of a speci®c degradation mechanism of
the translated enzyme. The existence of high levels of mRNA
at the infective, non-dividing, stationary phase parasites may
be useful for the protozoon in the macrophage, once
transformed into the amastigote phase, to initiate the rapid
division necessary for the survival of the parasite. The
existence of a pool of molecules ready to be used could be
one adaptive defense mechanism to counteract the macro-
phage attack. The amount of mRNA even increases in the
highly replicative intracellular amastigote but the crucial ®rst
hours in the mammal cell may be covered by the Li-TOP2
transcripts coming from the extracellular form of Leishmania.
The cloning and functional characterization of the Li topo II
are the ®rst steps towards a more detailed biochemical
characterization including in vitro analysis, which together
with a model of Li topo II de®ciency will serve to determine
the relevance of the enzyme to the infectivity and development
of L.infantum. This will allow its use as a speci®c target for
anti-parasite drugs, avoiding the treatment failures and
subsequent disease relapses that are now spreading visceral
Figure 5. Growth rate of Dtop1 top2-4 yeast cells expressing Li topo II.
Transformants of JCW28 cells, transformed either with pEMBLyex4 or
pEMBL-LiTopoII, were grown in selective media SD (±ura) containing dif-
ferent amounts (w/v) of galactose and glucose as indicated. Duplication
times (min) of each culture were measured during exponential growth.
Figure 6. DNA relaxation activity of L.infantum topoisomerase II in Dtop1
top2-4 yeast cells. Cultures containing 2% glucose or 2% galactose of
JCW28 cells harboring YeptopA-PGPD(LEU) plus pEMBLyex4 (lanes 1
and 2) or pEMBL-LiTopoII (lanes 3 and 4) were set as described in the
text. Cultures were shifted to 35°C for 2 h 30 min before cell harvesting.
DNA extracts were examined by two-dimensional electrophoresis, carried
out in a 0.6% agarose gel, that was run in TBE buffer plus 0.6 and 3 mg/ml
chloroquine in the ®rst (top to bottom, 12 h at 60 V) and second (left to
right, 6 h at 60 V) dimensions, respectively. The gel was blot-hybridized
with a 32P-labeled probe to reveal the 2m yeast plasmid (6.3 kb). The
positions of the arched distribution of topoisomerse and of the positively
supercoiled forms (S+) of the 2m are indicated. Bands appearing on the
upper half of the gel mostly correspond to multimeric forms of the 2m
plasmid, chromosomal DNA fragments and less abundant DNA plasmids.
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leishmaniasis. This has become a health hazard with important
economic and social consequences not only in traditionally
affected areas but also in the Northern Mediterranean basin.
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